How viruses affect tumors and treatment
Part of Blood & lymphatic, Cancer, Immune system & allergy, Infections clinical trials.
This study looks at how viruses change the environment around tumors, especially in cancers of the throat, lung, lymph nodes, and anal canal. It aims to understand why some treatments work better for virus-related cancers than others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these cancers: throat, lung (non-small cell), large B-cell lymphoma, or anal canal cancer.
- Your cancer is caused by a virus (like HPV, HIV, or EBV) or is not virus-related.
- You have tumor tissue available from before you started cancer treatment.
- You are being treated at a participating hospital in Paris.
- You agree to take part and are covered by French health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how viruses like HPV, HIV, and EBV change the environment around tumors and why some cancers resist treatment. If you have one of these virus-related cancers, your tumor samples will be studied to better understand resistance and find new treatment options.
This study looks at virus-related markers and tiny gene regulators (microRNAs) in tumor tissue from people with certain throat cancers caused by human papilloma virus (HPV). It’s observational, meaning it does not change your treatment, but results may help doctors better understand these cancers and how they behave.
This study collects blood and/or tumor-related samples to map how your immune system recognizes cancer. It aims to better understand immune targets and immune cell types, which may help guide future cancer treatments for certain virus-related cancers.
This study checks a blood test that looks for HPV tumor DNA to help doctors decide when to start routine treatment after surgery. It may help some people avoid starting treatment too early or too late based on how the test changes after the operation.
This Phase 2 study tests a “risk-adapted” treatment plan for HPV-related throat cancer, using an HPV DNA blood test to help decide how treatment is done. If your baseline blood test shows detectable HPV DNA, the study may help tailor therapy to your risk and potentially improve outcomes while limiting unnecessary treatment.
This early-phase study tests a lab-made treatment using your own immune cells (T cells) to target HPV-related throat cancers. It aims to reduce cancer by directing your immune system against HPV16/HPV18 and a protein called survivin.
Hear when a new Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.